TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
170,136
|
161,875
|
121,089 |
Financial expenses |
535
|
5
|
1 |
Earnings before taxes |
56,541
|
82,775
|
33,524 |
EBITDA |
54,569
|
81,843
|
34,048 |
Total assets |
124,209
|
119,526
|
107,120 |
Current assets |
117,384
|
114,219
|
101,324 |
Current liabilities |
54,586
|
35,873
|
15,672 |
Equity capital |
65,075
|
80,678
|
88,734 |
- share capital |
34
|
33
|
36 |
Employees (average) |
17
|
11
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.4%
|
67.5%
|
82.8% |
Turnover per employee |
10,008
|
14,716
|
20,182 |
Profit as a percentage of turnover |
33.2%
|
51.1%
|
27.7% |
Return on assets (ROA) |
46.0%
|
69.3%
|
31.3% |
Current ratio |
215.0%
|
318.4%
|
646.5% |
Return on equity (ROE) |
86.9%
|
102.6%
|
37.8% |
Change turnover |
7,427
|
50,595
|
121,089 |
Change turnover % |
5%
|
45% | |
Chg. No. of employees |
6
|
5
|
4 |
Chg. No. of employees % |
55%
|
83%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.